Showing results (61-70 of 665) with videos related to
Sort By:
Pageof 67
European Journal of Pharmacology|March 12, 1982
Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administrationP A Nausieda, P M Carvey, W J WeinerMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Delayed-onset dystonia associated with corticospinal tract dysfunctionS A Factor, J Sanchez-Ramos, W J WeinerMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Trauma as an etiology of parkinsonism: a historical review of the conceptS A Factor, J Sanchez-Ramos, W J WeinerNeurology|April 1, 1989
Cognitive impairments associated with early Parkinson's diseaseB E Levin, M M Llabre, W J WeinerNeurology|July 1, 1978
The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copperW J Weiner, P A Nausieda, H L KlawansMovement Disorders : Official Journal of the Movement Disorder Society|November 1, 1994
Coprolalia in younger patients with Gilles de la Tourette syndromeJ N Goldenberg, S B Brown, W J WeinerNeurology|December 1, 1981
Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapyW J Weiner, P A Nausieda, R H GlantzJournal of Neurology, Neurosurgery, and Psychiatry|November 1, 1988
Parkinson's disease and depression: psychometric properties of the Beck Depression InventoryB E Levin, M M Llabre, W J WeinerJournal of Neurology, Neurosurgery, and Psychiatry|April 1, 1988
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapyS A Factor, J R Sanchez-Ramos, W J WeinerJournal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's diseaseW J Weiner, S A Factor, J R Sanchez-RamosPageof 67